Morgan Stanley Downgrades Merck (MRK) to Underweight
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Price: $128.66 +2.56%
Rating Summary:
24 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Rating Summary:
24 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Join SI Premium – FREE
Morgan Stanley downgraded Merck (NYSE: MRK) from Equalweight to Underweight.
NOTE: Second downgrade today.
For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.
Shares of Merck closed at $41.83 yesterday.
NOTE: Second downgrade today.
For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.
Shares of Merck closed at $41.83 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Quest to Repair What Multiple Sclerosis Takes Away
- FDA approves Merck's Keytruda combo with Trodelvy for TNBC
- Macquarie Downgrades Luk Fook Holdings International Ltd. (590:HK) (LKFLF) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
